Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases
Open Access
- 11 October 2016
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 24 (1) , 236-243
Abstract
Background Several clinical risk scores for patients with colorectal liver metastases (CLM) were established in cohorts of patients undergoing liver resection (LR) without neoadjuvant chemotherapy...Keywords
This publication has 18 references indexed in Scilit:
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingAnnals of Oncology, 2012
- Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?Annals of Surgical Oncology, 2011
- Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literatureInternational Journal of Colorectal Disease, 2011
- Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastasesJournal of Surgical Oncology, 2009
- Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastasesLiver International, 2008
- Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Hepatic Resection for Colorectal MetastasesAnnals of Surgery, 2007
- Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal MetastasesAnnals of Surgery, 2005
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996